Royal Bank of Canada
ONEM

Royal Bank of Canada’s 1Life Healthcare ONEM Stock Holding History

Royal Bank of Canada’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-191,892
Closed -$3.21M – 7794
2022
Q4 		$3.21M Buy
191,892
+166,099
+644% +$2.81M ﹤0.01% 2503
2022
Q3 		$442K Buy
25,793
+667
+3% +$10.5K ﹤0.01% 4143
2022
Q2 		$198K Sell
25,126
-6,561
-21% -$56.4K ﹤0.01% 4810
2022
Q1 		$351K Sell
31,687
-946
-3% -$10.6K ﹤0.01% 4585
2021
Q4 		$573K Buy
32,633
+331
+1% +$6.42K ﹤0.01% 4340
2021
Q3 		$654K Buy
32,302
+6,218
+24% +$160K ﹤0.01% 4117
2021
Q2 		$863K Buy
26,084
+17,791
+215% +$672K ﹤0.01% 3790
2021
Q1 		$324K Sell
8,293
-127,390
-94% -$5.98M ﹤0.01% 4545
2020
Q4 		$5.92M Buy
135,683
+112,130
+476% +$3.83M ﹤0.01% 2075
2020
Q3 		$668K Sell
23,553
-103,047
-81% -$3.25M ﹤0.01% 3610
2020
Q2 		$4.6M Buy
126,600
+113,854
+893% +$3.21M ﹤0.01% 2000
2020
Q1 		$231K Buy
+12,746
New +$279K ﹤0.01% 4225

Royal Bank of Canada's ONEM Position: Q1 2023 in Review

Royal Bank of Canada sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 191,892 shares — an estimated $3.21M sold.

Royal Bank of Canada first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $5.92M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Royal Bank of Canada reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 191,892 1Life Healthcare shares in Q1 2023, an estimated $3.21M.
  • Royal Bank of Canada first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Royal Bank of Canada's 1Life Healthcare position peaked at $5.92M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.